ENFLONSIA
As listed in the register: ENFLONSIA
105 mg · solution
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Clesrovimab
- Made by
- Merck Canada Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (ENFLONSIA). It describes the substance, not this exact product.
ENFLONSIA is a monoclonal antibody with anti-RSV activity [see Microbiology (12.4) ].
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-06-20
Safety of the active substance
From the US prescribing label for the same active substance (ENFLONSIA). It describes the substance, not this exact product.
- ENFLONSIA is contraindicated in infants with a history of serious hypersensitivity reactions, including anaphylaxis, to any component of ENFLONSIA [see Warnings and Precautions (5.1) and Description (11) ].
Most common adverse reactions were injection-site erythema (3.8%), injection-site swelling (2.7%) and rash (2.3%).
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
FranceNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Merck Canada Inc |
|---|---|
| Active substance | Clesrovimab |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Strength | 105 mg |
| Form | solution |
| Classification | J06BD10 · Antibiotics, antivirals and antifungals taken into the body |
| Route | intramuscular |
| Dispensing (as stated by the register) | SCHEDULE D |
| Status | Approved |
| Marketed | No — authorised but not currently marketed, according to the register |
| DIN | 02565145 |
| DPD drug code | 106778 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.